EMA Issues Advice on Regeneron's Antibody Cocktail (casirivimab with imdevimab) for Certain COVID-19 Patients

Go back to EMA Issues Advice on Regeneron's Antibody Cocktail (casirivimab with imdevimab) for Certain COVID-19 Patients
Regeneron (NASDAQ: REGN) Delayed: 612.50 +2.56 (0.42%)
Previous Close $609.94    52 Week High $592.36 
Open $604.46    52 Week Low $325.35 
Day High $613.56    P/E 160.76 
Day Low $594.90    EPS $3.81 
Volume 1,604,280